MINI LONG - BB BIOTECH N Share Price

Certificat

DE000KB0PMU5

Delayed Börse Stuttgart 12:46:59 22/05/2024 pm IST
0.97 EUR -8.49% Intraday chart for MINI LONG - BB BIOTECH N
1 month+4.95%
3 months-37.28%
Date Price Change
22/24/22 0.97 -8.49%
21/24/21 1.06 -1.85%
20/24/20 1.08 -1.82%
17/24/17 1.1 +2.80%
16/24/16 1.07 +3.88%

Delayed Quote Börse Stuttgart

Last update May 22, 2024 at 12:46 pm IST

More quotes

Static data

Product typeKnock-Out con Stop Loss
Buy / SellCALL
Underlying BB BIOTECH AG
IssuerLogo Issuer Citi Citi
WKN KB0PMU
ISINDE000KB0PMU5
Date issued 13/03/2020
Strike 31.23 CHF
Maturity Unlimited
Parity 10 : 1
Emission price 0.95
Emission volume N/A
Settlement Por diferencias
Currency EUR

Technical Indicators

Highest since issue 5.46
Lowest since issue 0.39

Company Profile

BB Biotech AG is a Switzerland-based investment company, which principal activity is to invest in companies active in the biotechnology industry. BB Biotech AG invests mainly in companies operating in such sectors as oncology, infectious diseases, cardiovascular diseases, metabolic diseases and autoimmune diseases. The Company’s portfolio comprises between 20 and 35 companies and includes such companies as Celgene, Actelion, Vertex Pharmaceuticals, Gilead, Novo Nordisk, Incyte, Isis Pharmaceuticals, Immunogen, Halozyme Therapeutics, Ariad Pharmaceuticals, Biomarin Pharmaceutical, Alexion Pharmaceuticals, Optimer Pharmaceuticals, Achillion Pharmaceuticals, Swedish Orphan Biovitrum, Dendreon, Bavarian Nordic, Lupin, Glenmark Pharmaceuticals, Strides Arcolab, Endocyte, Probiodrug, and Idenix Pharmaceuticals.
Sector
-
More about the company

Ratings for BB Biotech AG

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

Consensus: BB Biotech AG

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
40.7 CHF
Average target price
47.7 CHF
Spread / Average Target
+17.20%
Consensus
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW